A Scientist Dedicated to Advancing Human Health

Dr. Sreekumar Raghavakaimal is a distinguished biomedical scientist whose career spans more than three decades of research at the intersection of chemistry, genomics, and medicine. After earning his Ph.D. in Organic Chemistry from the Indian Institute of Technology, Madras — one of India's most prestigious research institutions — he conducted extensive postdoctoral research at the University of Wisconsin, Madison.

At the Mayo Clinic in Rochester, Minnesota, Dr. Raghavakaimal built and directed two major core laboratories: the Genomics Center Microarray Core Laboratory and the Genomics, Proteomics and Metabolic Core Laboratory. In this capacity he supported 44 NIH-funded research grants and served 58 Mayo investigators — making him a central figure in the institution's biomedical research infrastructure.

His research has resulted in over 55 peer-reviewed publications in leading journals including Proceedings of the National Academy of Sciences (PNAS), Diabetes, Hepatology, and the Journal of Biological Chemistry. His work spans cancer genomics, diabetes and aging, liver disease, and the development of proteomic and bioinformatic tools for biomarker discovery.

Key Career Achievements

Mayo Clinic Director

Directed the Genomics Center Microarray Core Laboratory and Proteomics & Metabolic Core Laboratory (2001–2007), supporting 44 NIH grants.

NFCR Leadership

Senior Vice President and Chief Development Officer at the National Foundation for Cancer Research (2008–2014).

55+ Publications

Original research in PNAS, Diabetes, Hepatology, and the Journal of Biological Chemistry spanning three decades.

Scientific Contributions

Diabetes & Aging

Pioneered studies on mitochondrial function and skeletal muscle metabolism with K.S. Nair at Mayo Clinic, publishing landmark findings in Diabetes on insulin resistance and exercise as a countermeasure for aging. Learn more →

Liver Disease

Applied genomic and proteomic approaches to liver disease, hepatitis C, and transplantation outcomes, with findings published in Hepatology and Liver Transplantation. Learn more →

Cancer Genomics

Co-authored the mutational landscape study of gastric adenocarcinoma in Chinese patients, published in PNAS (2015), with direct implications for cancer prognosis and targeted therapy development.

Frequently Asked Questions

What is Dr. Sreekumar Raghavakaimal's professional background?

Dr. Sreekumar Raghavakaimal is a biomedical scientist with over 30 years of research experience. He earned his Ph.D. in Organic Chemistry from IIT Madras (1993), served as Director of the Mayo Clinic Genomics Center Microarray Core Laboratory (2001–2007), and served as Senior VP and CDO at the National Foundation for Cancer Research (2008–2014).

What research areas is Dr. Sreekumar Raghavakaimal known for?

Dr. Raghavakaimal is recognized for his work in genomics, proteomics, bioinformatics, and organic chemistry. His research spans diabetes and aging, liver disease, cancer biology, and mitochondrial function, with publications in PNAS, Diabetes, Hepatology, and the Journal of Biological Chemistry.

What was Dr. Sreekumar Raghavakaimal's role at the Mayo Clinic?

At Mayo Clinic, Dr. Raghavakaimal directed the Genomics Center Microarray Core Laboratory and the Genomics, Proteomics and Metabolic Core Laboratory (2001–2007), supporting 44 NIH grants and 58 Mayo investigators through microarray analysis, mass spectrometry, and bioinformatics services.

Is Dr. Sreekumar Raghavakaimal still active in science?

Yes. After his tenure at NFCR, Dr. Raghavakaimal has remained active as a science educator since 2015, teaching Math, Chemistry, Biology, and Physics at secondary and undergraduate levels. He brings his deep research expertise directly to the next generation of scientists.

What is Sreekumar Raghavakaimal known for in cancer research?

Dr. Raghavakaimal contributed to cancer research through genomic profiling and proteomics studies at NFCR and Mayo Clinic. His co-authored PNAS 2015 paper on the mutational landscape of gastric adenocarcinoma has direct implications for cancer prognosis and therapy.

Explore Dr. Sreekumar Raghavakaimal's Work

Browse the full academic record, publications, and media coverage.

View Full CV Research Publications Contact